ArticleBMC cancer2024

Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes.

Jinting Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.